These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6760532)

  • 21. Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes.
    Megid J; Appolinario CM; Mazzini AM; Almeida MF
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):192-6. PubMed ID: 16930720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of aluminum adjuvant to experimental rabies vaccine].
    Lin H; Perrin P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):133-5. PubMed ID: 12569779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunization of calves with a rabies vaccine from suckling mouse brain].
    Díaz AM; Lombardo RA
    Rev Argent Microbiol; 1981; 13(2):45-8. PubMed ID: 6765751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog.
    Cliquet F; Guiot AL; Schumacher C; Maki J; Cael N; Barrat J
    Dev Biol (Basel); 2008; 131():257-64. PubMed ID: 18634487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs.
    Bankovskiy D; Safonov G; Kurilchuk Y
    Dev Biol (Basel); 2008; 131():461-6. PubMed ID: 18634508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on candidate reference preparations of rabies vaccine.
    Wiktor TJ; Boegel K; Cox JH; Diaz AM; Fitzgerald E; Netter R; Turner G; Schneider LG; van Steenis G
    Dev Biol Stand; 1978; 40():187-93. PubMed ID: 355014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.
    Brookes SM; Parsons G; Johnson N; McElhinney LM; Fooks AR
    Vaccine; 2005 Jul; 23(32):4101-9. PubMed ID: 15964478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory techniques in rabies: Habel test for potency.
    Habel K
    Monogr Ser World Health Organ; 1973; (23):276-7. PubMed ID: 4219492
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory techniques in rabies: modified Habel test for potency.
    Habel K
    Monogr Ser World Health Organ; 1973; (23):278. PubMed ID: 4219493
    [No Abstract]   [Full Text] [Related]  

  • 40. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.